Therefore, tumor cells that express a Ser 194 FADD mutant that cannot be phosphorylated or are unable to phosphorylate FADD at this Ser position are expected to resist apoptosis induced by anticancer drugs that induce G2/M arrest, and to be insensitive to the synergistic effect of chemotherapy. The gene discussed is FADD; the disease is neoplasm.